Technical Analysis for KRYS - Krystal Biotech, Inc.

Grade Last Price % Change Price Change
grade D 56.825 1.42% 0.80
KRYS closed down 1.37 percent on Thursday, January 23, 2020, on 3.14 times normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up
Historical KRYS trend table...

Date Alert Name Type % Chg
Fell Below 50 DMA Bearish 1.42%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 1.42%
Volume Surge Other 1.42%
Inside Day Range Contraction 1.42%
Wide Bands Range Expansion 1.42%
Crossed Above 20 DMA Bullish 0.03%
Crossed Above 50 DMA Bullish 0.03%
MACD Bullish Signal Line Cross Bullish 0.03%
New Uptrend Bullish 0.03%
Pocket Pivot Bullish Swing Setup 0.03%

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Krystal Biotech, Inc. gene therapy company. The Company is engaged in developing and commercializing novel treatments for patients suffering from dermatological diseases. The Company has developed a Skin TARgeted Delivery platform, or STAR-D platform, that consists of a patent pending engineered viral vector based on herpes simplex virus 1, or HSV-1, and skin-optimized gene transfer technology, to develop off-the-shelf treatments for dermatological diseases. The Company’s products include KB103 and KB104.The Compnay's KB103 is in preclinical development to treat dystrophic epidermolysis bullosa, or DEB, a rare and severe genetic disease. The Compnay's KB104 is to treat Netherton Syndrome, a severe form of ichthyosis, which is a family of genetic skin disorders associated with thickened scaly skin and characterized by chronic skin inflammation, itchiness, dehydration and stunted growth.
Medicine Rare Diseases Gene Therapy Medical Genetics Genetic Genealogy Genodermatoses Herpes Simplex Virus Epidermolysis Bullosa Itchiness Netherton Syndrome

Is KRYS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 66.5
52 Week Low 18.5
Average Volume 179,199
200-Day Moving Average 43.29
50-Day Moving Average 56.27
20-Day Moving Average 54.73
10-Day Moving Average 51.63
Average True Range 3.85
ADX 24.0
+DI 22.51
-DI 20.60
Chandelier Exit (Long, 3 ATRs ) 51.89
Chandelier Exit (Short, 3 ATRs ) 56.77
Upper Bollinger Band 63.60
Lower Bollinger Band 45.86
Percent B (%b) 0.57
BandWidth 32.42
MACD Line -0.90
MACD Signal Line -1.21
MACD Histogram 0.3098
Fundamentals Value
Market Cap 540.32 Million
Num Shares 9.64 Million
EPS -0.63
Price-to-Earnings (P/E) Ratio -88.94
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 59.55
Resistance 3 (R3) 59.60 58.47 58.97
Resistance 2 (R2) 58.47 57.58 58.45 58.77
Resistance 1 (R1) 57.25 57.02 56.69 57.20 58.57
Pivot Point 56.13 56.13 55.84 56.10 56.13
Support 1 (S1) 54.90 55.23 54.34 54.86 53.49
Support 2 (S2) 53.78 54.67 53.75 53.29
Support 3 (S3) 52.56 53.78 53.09
Support 4 (S4) 52.51